Similarly, in chronic myelogenous leukemia carrying BCR-ABL fusion, PI3K-mTORC1 signaling downstream of BCR-ABL receptor tyrosine kinase (RTK) activity increases ROS through elevated glycolysis and mitochondrial respiration (Kim et al., 2005). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.